COVID-19 vaccination in Cameroon
| Date | April 12, 2021 |
|---|---|
| Cause | COVID-19 pandemic |
COVID-19 vaccination in Cameroon is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
Cameroon began its vaccination program on 12 April 2021, initially using the 200,000 doses of the Sinopharm BIBP vaccine donated by China.[1] As of 14 June 2021, 89,180 doses have been administered, 72,111 people with one dose and 17,069 people fully vaccinated.[2]
Background
History
Timeline
April 2021
By the end of the month 11,616 vaccine doses had been administered.[3]
May 2021
By the end of the month 75,215 doses had been administered.[3]
June 2021
By the end of the month 110,324 doses had been administered.[3]
July 2021
By the end of the month 343,657 doses had been administered.[3]
August 2021
By the end of the month 426,590 doses had been administered.[3]
September 2021
By the end of the month 461,201 doses had been administered.[3]
October 2021
By the end of the month 503,363 doses had been administered. 1% of the targeted population had been fully vaccinated.[3]
November 2021
By the end of the month 923,643 doses had been administered. 5% of the targeted population had been fully vaccinated.[3]
December 2021
By the end of the month 1.02 million doses had been administered. 6% of the targeted population had been fully vaccinated.[3]
January 2022
By the end of the month 1.02 million doses had been administered. 6% of the targeted population had been fully vaccinated.[3]
Progress
Cumulative vaccinations in Cameroon[4]
References
- ↑ Onoja, Johnson (13 April 2021). "Cameroon starts Covid vaccination using jabs given by China". BNN Africa. Retrieved 15 April 2021.
- ↑ "owid/covid-19-data". GitHub. Retrieved 19 June 2021.
- 1 2 3 4 5 6 7 8 9 10 Africa COVID-19 dashboard (World Health Organization).
- ↑ "owid/covid-19-data". GitHub. Retrieved 7 March 2021.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.svg.png.webp){kind=small}
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.